The European Neurointerventional radiology Devices Market is mainly driven by gradual technological evolution, growing ageing and obese population, rising patient pool suffering from ischemic and hemorrhagic stroke and increasing demand for minimally invasive surgical procedures. The European neurointerventional radiology devices market was valued at $427.45 million in 2013 and will reach $546.10 million by 2018 at a CAGR of 5.0%. Aneurysm Coiling & Arteriovenous Malformation Embolization & Fistula embolization segment accounts for the largest share of 60% of the global neurointerventional radiology devices market, followed by support devices (17%), cerebral balloon angioplasty & stenting systems (15%) and neurothrombectomy devices (8%) in 2012.
The report “European Neurointerventional radiology Devices Market forecast, 2011-2018” analyzes the market categorizes of the neurointerventional radiology devices market for devices by 5 segments such as neurothrombectomy devices (suction/aspiration device, clot retriever, and snare device), cerebral angiography and stenting system (carotid stent, and embolic protection system), aneurysm coiling devices (platinum coil, liquid embolic agents, and flow diversion device) and support devices (microcatheter, and microguidewire). All of these segments experienced a positive growth, with an increased awareness for procedures and sophisticated diagnostic techniques. Neurothrombectomy devices and cerebral angiography markets have been witnessing the maximum growth because of increase in patient pool and procedure numbers of Aneurysm Coiling , Arteriovenous Malformation Embolization & Fistula embolization .
Procedure Volume growth is significantly higher in Europe market including Germany, France and Italy, expected to grow at a higher pace due to the effect of growing GDP and purchasing capability of healthcare institutions in those countries, fast disease progression, higher prevalence, broadening insurance coverage, expanding private healthcare sector and increasing awareness amongst people. The high prevalence of people suffering from ischemic and hemorrhagic stroke 8-10% in Europe is because of high diabetes and obese population.
The report also provides an extensive competitive landscaping of companies operating in European Neurointerventional Radiology market. The main companies operating in European Neurointerventional Radiology devices market and extensively covered in this report are Covidien, PLC (Ireland), Stryker Corporation (U.S.), Johnson & Johnson (U.S.), and Penumbra, Inc. (U.S.)..
Segment and country specific Company shares, News & Deals, M&A, segment specific pipeline products, product approvals and product recalls of the major companies have been detailed.
Customization Options:
Along with market data, you can also customize MMM assessments that meet your company’s specific needs. Customize to get comprehensive industry standard and deep dive analysis of the following parameters:
Product Analysis
- Usage pattern (in-depth trend analysis) of products (Segment wise)
- Product Matrix which gives a detailed comparison of product portfolio of each company mapped at country and sub segment level
- End-user Adoption rate analysis of the products (Segment wise and Country wise)
- Comprehensive coverage of Product approvals, Pipeline products and Product recalls
Epidemiology Data
- Country specific Prevalence of ischemic and hemorrhagic stroke
- Country specific Patient pool of ischemic and hemorrhagic stroke
- Disease progression (Pattern analysis)
Procedure Volume Data
- Bilateral and Unilateral Neurointerventional procedures performed annually in each Country tracked till sub-segment level
- Number of neurothrombectomy, cerebral balloon angioplasty & stenting procedures performed in each country
Surgeons / Physicians Perception analysis
- Fast turn-around analysis of Surgeons response to market events and trends
- Pattern analysis of usage of Aneurysm Coiling, Arteriovenous Malformation Embolization & Fistula embolization by Physicians
- Surgeons opinion about products from different companies
- Surgeons qualitative inputs on epidemiology data
Brand/Product Perception Matrix
- Comprehensive study of customers perception and behavior through our inbuilt social connect tool checking the virality and tonality of blogs
- Analysis of overall brand usage and familiarity and brand advocacy distribution (Detractor/Neutral/Familiar)
Pricing Trends
- Cost analysis of the European Neurointerventional Radiology Devices
- Neurothrombectomy, cerebral balloon angioplasty & stenting procedural investment for the North American region
Competitive Intelligence
- The company share analysis of the European Neurointerventional Radiology Devices market top players in the region
- The crucial developments and strategies of companies inculcating in their portfolio for the European Neurointerventional Radiology Devices
1 Introduction
1.1 Objective of the study
1.2 Market Definitions
1.3 Market Segmentation & Aspects Covered
1.4 Research Methodology
1.4.1 Assumptions (Market Size, Forecast, etc)
2 Executive Summary
3 Market Overview
4 Neurointerventional Devices-Europe, By Products
4.1 Neurothrobectomy Devices-Europe
4.1.1 Neurothrobectomy Devices-Europe, By Subproducts
4.1.1.1 Suction/Aspiration Device-Europe
4.1.1.2 Clot Retriever-Europe
4.1.1.3 Snare Devices-Europe
4.2 Cerebral Ballon Angioplasty & Stenting Sytems-Europe
4.2.1 Cerebral Ballon Angioplasty & Stenting Sytems-Europe, By Products
4.2.1.1 Carotid Artery Stents-Europe
4.2.1.2 Embolic Protection Systems-Europe
4.3 Embolization Devices-Europe
4.3.1 Embolization Devices-Europe, By Products
4.3.1.1 Flow Diversion Devices-Europe
4.3.1.2 Embolic Coil-Europe
4.3.1.3 Liquid Embolic Agents-Europe
4.4 Support Devices-Europe
4.4.1 Support Devices-Europe, By Products
4.4.1.1 Microcatheters-Europe
4.4.1.2 Microguidewires-Europe
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement